Home › Funds › Alta Fundamental Advisers LLC › INDV

Alta Fundamental Advisers LLC position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Alta Fundamental Advisers LLC reported holding 404,529 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$14.5M, representing 6.44% of its reported portfolio and ranking #5 among its reported holdings. Alta Fundamental Advisers LLC has disclosed INDV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)404.53K sh
Reported value held$14.50M
Portfolio Weight6.44%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Alta Fundamental Advisers LLC's INDV position evolved

Alta Fundamental Advisers LLC first disclosed a stake in INDV in Q3 2023 at 150,000 shares (US$2.7M). The position peaked in Q2 2026 at 404,529 shares, worth US$16.6M. Across 13 filings, Alta Fundamental Advisers LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 404,529 shares valued at US$14.5M. Notable position changes include a 117% increase in Q2 2024 (shares fell 23% over the following quarter), a 72% increase in Q2 2025 (shares rose 64% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 150.00K $2.67M New
Q4 2023 150.00K $1.78M Hold
Q1 2024 150.00K $2.54M Hold
Q2 2024 325.00K $4.03M Add
Q3 2024 325.00K $2.39M Hold
Q4 2024 400.00K $4.97M Add
Q1 2025 334.47K $3.19M Reduce
Q2 2025 575.05K $8.48M Add
Q3 2025 475.05K $11.45M Reduce
Q4 2025 409.53K $14.69M Reduce
Q1 2026 409.53K $12.48M Hold
Q2 2026 404.53K $16.60M Reduce
Q3 2026 404.53K $14.50M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Alta Fundamental Advisers LLC held INDV?

Alta Fundamental Advisers LLC has disclosed INDV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Alta Fundamental Advisers LLC's current position in INDV?

As of Q3 2026, Alta Fundamental Advisers LLC holds 404.53K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $14.50M, representing 6.44% of its reported portfolio and ranking #5.

Has Alta Fundamental Advisers LLC been buying or selling INDV?

In the latest 13F filing (Q3 2026), Alta Fundamental Advisers LLC held unchanged its position in INDV. The position peaked in Q2 2026 at 404.53K shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.